Drug Type Synthetic peptide |
Synonyms MEN 11558 |
Target |
Mechanism NK2R antagonists(Neurokinin 2 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC33H35N5O4 |
InChIKeyPRRYSNSLFNBYDL-IGBKUBFESA-N |
CAS Registry211689-03-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Preclinical | IT | - | |
Cystitis | Preclinical | IT | - | |
Irritable Bowel Syndrome | Preclinical | IT | - |